{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:07:54Z","timestamp":1791925674674,"version":"4.3.4"},"reference-count":77,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-119321"],"award-info":[{"award-number":["MOP-119321"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-2015-03790"],"award-info":[{"award-number":["RGPIN-2015-03790"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0220254","type":"journal-article","created":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T13:38:42Z","timestamp":1566481122000},"page":"e0220254","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":62,"title":["Proprotein convertase subtilisin\/kexin type 9 (PCSK9) in Alzheimer\u2019s disease: A genetic and proteomic multi-cohort study"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1107-6839","authenticated-orcid":true,"given":"Cynthia","family":"Picard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Poirier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"B\u00e9langer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8076-7540","authenticated-orcid":true,"given":"Anne","family":"Labont\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9486-1105","authenticated-orcid":true,"given":"Daniel","family":"Auld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judes","family":"Poirier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the PREVENT-AD Research Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,8,22]]},"reference":[{"issue":"9753","key":"pone.0220254.ref001","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"C Cholesterol Treatment Trialists","year":"2010","journal-title":"Lancet"},{"issue":"8","key":"pone.0220254.ref002","first-page":"787","article-title":"Evolocumab in Patients with Cardiovascular Disease","volume":"377","author":"MS Sabatine","year":"2017","journal-title":"N Engl J Med"},{"issue":"7","key":"pone.0220254.ref003","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0002-9343(00)00353-3","article-title":"Effects of lovastatin on cognitive function and psychological well-being","volume":"108","author":"MF Muldoon","year":"2000","journal-title":"Am J Med"},{"issue":"11","key":"pone.0220254.ref004","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.amjmed.2004.07.041","article-title":"Randomized trial of the effects of simvastatin on cognitive functioning in hypercholesterolemic adults","volume":"117","author":"MF Muldoon","year":"2004","journal-title":"Am J Med"},{"issue":"16","key":"pone.0220254.ref005","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJMoa1501031","article-title":"Efficacy and safety of alirocumab in reducing lipids and cardiovascular events","volume":"372","author":"JG Robinson","year":"2015","journal-title":"N Engl J Med"},{"issue":"6","key":"pone.0220254.ref006","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/eurheartj\/ehv563","article-title":"The impact of proprotein convertase subtilisin-kexin type 9 serine protease inhibitors on lipid levels and outcomes in patients with primary hypercholesterolaemia: a network meta-analysis","volume":"37","author":"MJ Lipinski","year":"2016","journal-title":"Eur Heart J"},{"issue":"20","key":"pone.0220254.ref007","first-page":"1997","article-title":"Cognitive Function in a Randomized Trial of Evolocumab","volume":"377","author":"RP Giugliano","year":"2017","journal-title":"N Engl J Med"},{"issue":"6","key":"pone.0220254.ref008","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/CIRCRESAHA.114.301621","article-title":"PCSK9: a key modulator of cardiovascular health","volume":"114","author":"NG Seidah","year":"2014","journal-title":"Circ Res"},{"issue":"7","key":"pone.0220254.ref009","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1194\/jlr.M014118","article-title":"PCSK9 reduces the protein levels of the LDL receptor in mouse brain during development and after ischemic stroke","volume":"52","author":"E Rousselet","year":"2011","journal-title":"J Lipid Res"},{"issue":"15","key":"pone.0220254.ref010","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.1073\/pnas.0501652102","article-title":"Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9","volume":"102","author":"S Rashid","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"pone.0220254.ref011","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/embor.2008.132","article-title":"PCSK9 is required for the disposal of non\u2010acetylated intermediates of the nascent membrane protein BACE1","volume":"9","author":"MC Jonas","year":"2008","journal-title":"EMBO reports"},{"issue":"9","key":"pone.0220254.ref012","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1194\/jlr.M006635","article-title":"PCSK9 is not involved in the degradation of LDL receptors and BACE1 in the adult mouse brain","volume":"51","author":"M Liu","year":"2010","journal-title":"Journal of Lipid Research"},{"issue":"12","key":"pone.0220254.ref013","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease","volume":"45","author":"JC Lambert","year":"2013","journal-title":"Nat Genet"},{"issue":"9","key":"pone.0220254.ref014","doi-asserted-by":"crossref","first-page":"e1004606","DOI":"10.1371\/journal.pgen.1004606","article-title":"Genome-Wide Association Meta-analysis of Neuropathologic Features of Alzheimer's Disease and Related Dementias","volume":"10","author":"GW Beecham","year":"2014","journal-title":"PLoS Genet"},{"issue":"1","key":"pone.0220254.ref015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FPC.0000000000000178","article-title":"Role of rs3846662 and HMGCR alternative splicing in statin efficacy and baseline lipid levels in familial hypercholesterolemia","volume":"26","author":"V Leduc","year":"2016","journal-title":"Pharmacogenet Genomics"},{"issue":"7","key":"pone.0220254.ref016","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/mp.2014.81","article-title":"HMGCR is a genetic modifier for risk, age of onset and MCI conversion to Alzheimer's disease in a three cohorts study","volume":"20","author":"V Leduc","year":"2015","journal-title":"Mol Psychiatry"},{"key":"pone.0220254.ref017","doi-asserted-by":"crossref","first-page":"180 e1","DOI":"10.1016\/j.neurobiolaging.2018.01.018","article-title":"Alterations in cholesterol metabolism-related genes in sporadic Alzheimer's disease","volume":"66","author":"C Picard","year":"2018","journal-title":"Neurobiol Aging"},{"issue":"7","key":"pone.0220254.ref018","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1016\/S0021-9258(18)69082-9","article-title":"Operator constitutive mutation of 3-hydroxy-3-methylglutaryl coenzyme A reductase promoter abolishes protein binding to sterol regulatory element","volume":"263","author":"TF Osborne","year":"1988","journal-title":"J Biol Chem"},{"issue":"4","key":"pone.0220254.ref019","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/S0021-9258(19)39976-4","article-title":"Identification of nucleotides responsible for enhancer activity of sterol regulatory element in low density lipoprotein receptor gene","volume":"265","author":"JR Smith","year":"1990","journal-title":"J Biol Chem"},{"issue":"2","key":"pone.0220254.ref020","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1194\/jlr.M700443-JLR200","article-title":"Sterol-dependent regulation of proprotein convertase subtilisin\/kexin type 9 expression by sterol-regulatory element binding protein-2","volume":"49","author":"HJ Jeong","year":"2008","journal-title":"J Lipid Res"},{"issue":"2","key":"pone.0220254.ref021","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3233\/JAD-2001-3207","article-title":"Cholesterol depletion with physiological concentrations of a statin decreases the formation of the Alzheimer amyloid Abeta peptide","volume":"3","author":"JD Buxbaum","year":"2001","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"pone.0220254.ref022","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.1073\/pnas.081620098","article-title":"Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo","volume":"98","author":"K Fassbender","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"pone.0220254.ref023","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/ncb1001-905","article-title":"Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid beta-peptide","volume":"3","author":"L Puglielli","year":"2001","journal-title":"Nat Cell Biol"},{"issue":"5","key":"pone.0220254.ref024","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1006\/nbdi.2001.0422","article-title":"A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease","volume":"8","author":"LM Refolo","year":"2001","journal-title":"Neurobiol Dis"},{"issue":"1","key":"pone.0220254.ref025","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000231980","article-title":"Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later","volume":"28","author":"A Solomon","year":"2009","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"3","key":"pone.0220254.ref026","doi-asserted-by":"crossref","first-page":"149","DOI":"10.7326\/0003-4819-137-3-200208060-00006","article-title":"Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease","volume":"137","author":"M Kivipelto","year":"2002","journal-title":"Ann Intern Med"},{"issue":"2","key":"pone.0220254.ref027","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1212\/01.WNL.0000149519.47454.F2","article-title":"Midlife cardiovascular risk factors and risk of dementia in late life","volume":"64","author":"RA Whitmer","year":"2005","journal-title":"Neurology"},{"issue":"9242","key":"pone.0220254.ref028","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(00)03155-X","article-title":"Statins and the risk of dementia","volume":"356","author":"H Jick","year":"2000","journal-title":"Lancet"},{"issue":"2","key":"pone.0220254.ref029","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/archneur.59.2.223","article-title":"Use of Lipid-Lowering Agents, Indication Bias, and the Risk of Dementia in Community-Dwelling Elderly People","volume":"59","author":"K Rockwood","year":"2002","journal-title":"Arch Neurol"},{"issue":"1","key":"pone.0220254.ref030","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1741-7015-5-20","article-title":"Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease","volume":"5","author":"B Wolozin","year":"2007","journal-title":"BMC Med"},{"issue":"19","key":"pone.0220254.ref031","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1001\/jama.2008.683","article-title":"Ginkgo biloba for prevention of dementia: a randomized controlled trial","volume":"300","author":"ST DeKosky","year":"2008","journal-title":"JAMA"},{"issue":"1","key":"pone.0220254.ref032","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13195-017-0237-y","article-title":"Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer's disease","volume":"9","author":"N Geifman","year":"2017","journal-title":"Alzheimers Res Ther"},{"key":"pone.0220254.ref033","article-title":"Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease. LEADe","author":"HH Feldman","year":"2010","journal-title":"Neurology"},{"issue":"6","key":"pone.0220254.ref034","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1212\/WNL.0b013e318228bf11","article-title":"A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease","volume":"77","author":"M Sano","year":"2011","journal-title":"Neurology"},{"issue":"11","key":"pone.0220254.ref035","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/archneur.1985.04060100083029","article-title":"Diagnosis of Alzheimer's disease","volume":"42","author":"ZS Khachaturian","year":"1985","journal-title":"Arch Neurol"},{"issue":"1","key":"pone.0220254.ref036","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3233\/JAD-150883","article-title":"Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics","volume":"52","author":"N Lelental","year":"2016","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"pone.0220254.ref037","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: a tool set for whole-genome association and population-based linkage analyses","volume":"81","author":"S Purcell","year":"2007","journal-title":"Am J Hum Genet"},{"issue":"10","key":"pone.0220254.ref038","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/ng.3643","article-title":"A reference panel of 64,976 haplotypes for genotype imputation","volume":"48","author":"S McCarthy","year":"2016","journal-title":"Nat Genet"},{"issue":"2","key":"pone.0220254.ref039","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nmeth.1785","article-title":"A linear complexity phasing method for thousands of genomes","volume":"9","author":"O Delaneau","year":"2011","journal-title":"Nat Methods"},{"issue":"9","key":"pone.0220254.ref040","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1093\/bioinformatics\/btu014","article-title":"Efficient haplotype matching and storage using the positional Burrows-Wheeler transform (PBWT)","volume":"30","author":"R. Durbin","year":"2014","journal-title":"Bioinformatics"},{"issue":"2","key":"pone.0220254.ref041","doi-asserted-by":"crossref","first-page":"e16616","DOI":"10.1371\/journal.pone.0016616","article-title":"Meta-analysis for genome-wide association study identifies multiple variants at the BIN1 locus associated with late-onset Alzheimer's disease","volume":"6","author":"X Hu","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"pone.0220254.ref042","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jalz.2017.12.004","article-title":"CDK5RAP2 gene and tau pathophysiology in late-onset sporadic Alzheimer's disease","volume":"14","author":"J Miron","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"2","key":"pone.0220254.ref043","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0009-8981(91)90070-S","article-title":"Clinical relevance of the quantification of apolipoprotein E in cerebrospinal fluid","volume":"196","author":"J Carlsson","year":"1991","journal-title":"Clinica Chimica Acta"},{"issue":"7","key":"pone.0220254.ref044","doi-asserted-by":"crossref","first-page":"P118","DOI":"10.1016\/j.jalz.2015.07.016","article-title":"Mapping the progression of CSF and imaging biomarkers in \u201cat-risk\u201d healthy subjects: The prevent-ad program.","volume":"11","author":"J Poirier","year":"2015","journal-title":"Alzheimer's & Dementia: The Journal of the Alzheimer's Association"},{"issue":"3","key":"pone.0220254.ref045","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s12020-016-0939-0","article-title":"Proprotein convertase subtilisin\/kexin type 9 (PCSK9) and metabolic syndrome: insights on insulin resistance, inflammation, and atherogenic dyslipidemia","volume":"54","author":"N Ferri","year":"2016","journal-title":"Endocrine"},{"issue":"9","key":"pone.0220254.ref046","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.tibs.2008.06.005","article-title":"PCSK9 and LDL cholesterol: unravelling the target to design the bullet","volume":"33","author":"P Costet","year":"2008","journal-title":"Trends Biochem Sci"},{"issue":"3","key":"pone.0220254.ref047","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1073\/pnas.0335507100","article-title":"The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation","volume":"100","author":"NG Seidah","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"pone.0220254.ref048","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11745-014-3895-6","article-title":"PCSK9 is present in human cerebrospinal fluid and is maintained at remarkably constant concentrations throughout the course of the day","volume":"49","author":"YQ Chen","year":"2014","journal-title":"Lipids"},{"issue":"5","key":"pone.0220254.ref049","doi-asserted-by":"crossref","first-page":"e64145","DOI":"10.1371\/journal.pone.0064145","article-title":"Proprotein convertase subtilisin\/kexin type 9 (PCSK9) can mediate degradation of the low density lipoprotein receptor-related protein 1 (LRP-1)","volume":"8","author":"M Canuel","year":"2013","journal-title":"PLoS One"},{"key":"pone.0220254.ref050","article-title":"Brain lipoprotein metabolism and relation to neurodegenerative disease","author":"M Danik","year":"2000","journal-title":"Critical Reviews in Neurobiology"},{"issue":"11","key":"pone.0220254.ref051","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.numecd.2011.06.002","article-title":"Proprotein convertase subtilisin\/kexin type 9 (PCSK9): From structure\u2013function relation to therapeutic inhibition","volume":"21","author":"G Tibolla","year":"2011","journal-title":"Nutrition, Metabolism and Cardiovascular Diseases"},{"issue":"12","key":"pone.0220254.ref052","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence Variations in PCSK9, Low LDL, and Protection against Coronary Heart Disease","volume":"354","author":"JC Cohen","year":"2006","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"pone.0220254.ref053","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1177\/0891988718764330","article-title":"Loss-of-Function PCSK9 Mutations Are Not Associated With Alzheimer Disease","volume":"31","author":"M Paquette","year":"2018","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"2","key":"pone.0220254.ref054","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1194\/jlr.M033969","article-title":"PCSK9 SNP rs11591147 is associated with low cholesterol levels but not with cognitive performance or noncardiovascular clinical events in an elderly population","volume":"54","author":"I Postmus","year":"2013","journal-title":"J Lipid Res"},{"issue":"5","key":"pone.0220254.ref055","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1073\/pnas.051630598","article-title":"An orchestrated gene expression component of neuronal programmed cell death revealed by cDNA array analysis","volume":"98","author":"LW Chiang","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"pone.0220254.ref056","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.molmed.2010.07.008","article-title":"APOE and cholesterol homeostasis in Alzheimer's disease","volume":"16","author":"V Leduc","year":"2010","journal-title":"Trends Mol Med"},{"issue":"1","key":"pone.0220254.ref057","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0306-4522(93)90456-P","article-title":"Cholesterol-Synthesis and Lipoprotein Reuptake During Synaptic Remodeling in Hippocampus in Adult-Rats","volume":"55","author":"J Poirier","year":"1993","journal-title":"Neuroscience"},{"issue":"7","key":"pone.0220254.ref058","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0022-2275(20)31605-9","article-title":"Characterization of four lipoprotein classes in human cerebrospinal fluid","volume":"42","author":"S Koch","year":"2001","journal-title":"J Lipid Res"},{"issue":"4","key":"pone.0220254.ref059","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2217\/clp.10.37","article-title":"Apolipoproteins in the brain: implications for neurological and psychiatric disorders","volume":"51","author":"DA Elliott","year":"2010","journal-title":"Clin Lipidol"},{"issue":"4","key":"pone.0220254.ref060","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1074\/jbc.M708098200","article-title":"The proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor (LDLR) and its closest family members VLDLR and ApoER2","volume":"283","author":"S Poirier","year":"2008","journal-title":"J Biol Chem"},{"issue":"4","key":"pone.0220254.ref061","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1046\/j.1471-4159.1998.70041458.x","article-title":"beta-amyloid peptides increase the binding and internalization of apolipoprotein E to hippocampal neurons","volume":"70","author":"U Beffert","year":"1998","journal-title":"Journal of Neurochemistry"},{"issue":"9","key":"pone.0220254.ref062","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/iub.1314","article-title":"Apolipoprotein E isoforms and lipoprotein metabolism","volume":"66","author":"MC Phillips","year":"2014","journal-title":"IUBMB Life"},{"issue":"51","key":"pone.0220254.ref063","doi-asserted-by":"crossref","first-page":"10881","DOI":"10.1021\/bi1017655","article-title":"Molecular basis for the differences in lipid and lipoprotein binding properties of human apolipoproteins E3 and E4","volume":"49","author":"D Nguyen","year":"2010","journal-title":"Biochemistry"},{"issue":"29","key":"pone.0220254.ref064","doi-asserted-by":"crossref","first-page":"14352","DOI":"10.1016\/S0021-9258(18)47945-8","article-title":"Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain","volume":"262","author":"RE Pitas","year":"1987","journal-title":"Journal of Biological Chemistry"},{"issue":"4","key":"pone.0220254.ref065","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.3233\/JAD-170993","article-title":"PCSK9 Concentrations in Cerebrospinal Fluid Are Not Specifically Increased in Alzheimer's Disease","volume":"62","author":"H Courtemanche","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"pone.0220254.ref066","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.nbd.2011.06.010","article-title":"Dysregulation of SREBP2 induces BACE1 expression","volume":"44","author":"R Mastrocola","year":"2011","journal-title":"Neurobiol Dis"},{"issue":"2","key":"pone.0220254.ref067","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3892\/mmr.2016.6055","article-title":"Hyperlipidemia-induced apoptosis of hippocampal neurons in apoE(-\/-) mice may be associated with increased PCSK9 expression","volume":"15","author":"XS Zhao","year":"2017","journal-title":"Mol Med Rep"},{"issue":"2","key":"pone.0220254.ref068","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.atherosclerosis.2008.02.004","article-title":"Berberine decreases PCSK9 expression in HepG2 cells","volume":"201","author":"J Cameron","year":"2008","journal-title":"Atherosclerosis"},{"issue":"2","key":"pone.0220254.ref069","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.bbrc.2006.11.043","article-title":"Berberine alters the processing of Alzheimer's amyloid precursor protein to decrease Abeta secretion","volume":"352","author":"M Asai","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"pone.0220254.ref070","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/nm1135","article-title":"Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins","volume":"10","author":"W Kong","year":"2004","journal-title":"Nat Med"},{"issue":"24","key":"pone.0220254.ref071","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1016\/j.lfs.2005.02.033","article-title":"Kinetic difference of berberine between hippocampus and plasma in rat after intravenous administration of Coptidis rhizoma extract","volume":"77","author":"X Wang","year":"2005","journal-title":"Life Sci"},{"issue":"8","key":"pone.0220254.ref072","doi-asserted-by":"crossref","first-page":"6732","DOI":"10.3390\/molecules16086732","article-title":"Berberine: a potential multipotent natural product to combat Alzheimer's disease","volume":"16","author":"HF Ji","year":"2011","journal-title":"Molecules"},{"issue":"5","key":"pone.0220254.ref073","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jacl.2018.05.012","article-title":"PCSK9 and neurocognitive function: Should it be still an issue after FOURIER and EBBINGHAUS results?","volume":"12","author":"MR Mannarino","year":"2018","journal-title":"J Clin Lipidol"},{"key":"pone.0220254.ref074","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cca.2015.03.036","article-title":"Relationship between testosterone, estradiol and circulating PCSK9: Cross-sectional and interventional studies in humans","volume":"446","author":"TC Ooi","year":"2015","journal-title":"Clin Chim Acta"},{"issue":"2","key":"pone.0220254.ref075","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1194\/jlr.M055780","article-title":"Influence of physiological changes in endogenous estrogen on circulating PCSK9 and LDL cholesterol","volume":"56","author":"M Ghosh","year":"2015","journal-title":"J Lipid Res"},{"issue":"16","key":"pone.0220254.ref076","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A Meta analysis","volume":"278","author":"LA Farrer","year":"1997","journal-title":"JAMA"},{"issue":"6","key":"pone.0220254.ref077","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.neurobiolaging.2006.04.005","article-title":"Gender-specific association of ATP-binding cassette transporter 1 (ABCA1) polymorphisms with the risk of late-onset Alzheimer's disease","volume":"28","author":"PD Sundar","year":"2007","journal-title":"Neurobiol Aging"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0220254","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T00:15:55Z","timestamp":1664151355000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0220254"}},"subtitle":[],"editor":[{"given":"Madepalli K.","family":"Lakshmana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,8,22]]},"references-count":77,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0220254","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,22]]}}}